Synthetic spadin-derived heptapeptide (TREK-1 inhibitor)
PE-22-28
Research use only
Written by pep4U Editorial Team · Last reviewed July 8, 2026
A seven-amino-acid peptide engineered from spadin that is being researched as a fast-acting antidepressant candidate.
| Class / type | Synthetic spadin-derived heptapeptide (TREK-1 inhibitor) |
|---|
| Category | Cognitive & Nootropic |
|---|
| Status (Jul 2026) | Research use only |
|---|
How it works
It blocks the TREK-1 two-pore-domain potassium channel in mood- and cognition-related brain regions, which increases neuronal excitability and is associated with enhanced neurogenesis and rapid antidepressant-like effects.
Known / used for
Preclinical research into depression, mood disorders, and neurogenesis.
Positives
In rodent models it produces rapid antidepressant-like effects with improved potency, stability, and duration compared with spadin.
Negatives & risks
No human clinical trials; whether TREK-1 blockade produces real antidepressant effects in people is unproven; long-term safety unknown; sold only as an unregulated research chemical.
What people like most (reported community sentiment - not endorsement)
Some experimenters report mood and motivation benefits, but reports are anecdotal and unverified.
Frequently asked questions
What is PE-22-28?
A seven-amino-acid peptide engineered from spadin that is being researched as a fast-acting antidepressant candidate. It blocks the TREK-1 two-pore-domain potassium channel in mood- and cognition-related brain regions, which increases neuronal excitability and is associated with enhanced neurogenesis and rapid antidepressant-like effects.
What is PE-22-28 used or researched for?
Preclinical research into depression, mood disorders, and neurogenesis.
Is PE-22-28 FDA-approved or legal?
NOT FDA-approved for any indication; it is an unapproved research chemical sold for laboratory use only and not authorized for human use.
What are the main risks or downsides of PE-22-28?
No human clinical trials; whether TREK-1 blockade produces real antidepressant effects in people is unproven; long-term safety unknown; sold only as an unregulated research chemical.
Legal / regulatory status
NOT FDA-approved for any indication; it is an unapproved research chemical sold for laboratory use only and not authorized for human use.
Recommended supplies
See all supplies →As an Amazon Associate we earn from qualifying purchases.
← Back to Cognitive & Nootropic